Table 3. Characteristics of Type 2 Diabetic Patients With the Highest Compared to Other Three Quartiles of SD-LDLC Combined.
| Quartiles of SD-LDLC |
P values | ||
|---|---|---|---|
| Other three (n = 122) | Highest (n = 40) | ||
| Male sex (n, %) | 69 (57) | 20 (50) | 0.47 |
| Age (years) | 63 ± 10 | 60 ± 11 | 0.15 |
| Smokers (n, %) | 39 (32) | 14 (35) | 0.75 |
| BMI (kg/m2) | 24.1 ± 3.7 | 24.6 ± 3.8 | 0.49 |
| Waist circumference (cm) | 86.2 ± 8.4 | 89.4 ± 13.6 | 0.08 |
| Duration of diabetes (years) | 9.4 ± 7.1 | 10.5 ± 7.8 | 0.40 |
| Treatment of diabetes | |||
| Diet/OHA/insulin (n, %) | 41/58/23 (34/48/19) | 12/23/5 (30/58/13) | 0.49 |
| Users of CCB/RASi/diuretics (n, %) | 46/53/6 (38/43/5) | 10/15/1 (25/38/3) | 0.32 |
| Users of hypolipidemic drugs (n, %) | 38 (31) | 23 (58) | 0.003 |
| HbA1c (%) | 7.0 ± 0.9 | 7.0 ± 0.8 | 0.94 |
| Fasting PG (mg/dL) | 125 ± 22 | 126 ± 24 | 0.79 |
| Post-breakfast PG (mg/dL) | 157 ± 49 | 142 ± 46 | 0.11 |
| CV-HbA1c (%) | 5.9 ± 5.2 | 9.1 ± 6.7 | 0.002 |
| Total cholesterol (mg/dL) | 185 ± 21 | 197 ± 20 | 0.003 |
| LDLC (mg/dL) | 109 ± 22 | 121 ± 21 | 0.002 |
| SD-LDLC (mg/dL) | 11 ± 4 | 30 ± 8 | 0.000 |
| HDLC (mg/dL) | 56 ± 16 | 54 ± 14 | 0.47 |
| Fasting TG (mg/dL) | 109 ± 49 | 132 ± 52 | 0.01 |
| Post-breakfast TG (mg/dL) | 140 ± 61 | 164 ± 65 | 0.05 |
| Serum creatinine (mg/dL) | 0.8 ± 0.2 | 0.7 ± 0.2 | 0.34 |
| eGFR (mL/min/1.73 m2) | 75 ± 16 | 79 ± 18 | 0.10 |
| Uric acid (mg/dL) | 5.2 ± 1.4 | 5.2 ± 1.0 | 0.85 |
| Systolic BP (mm Hg) | 128 ± 12 | 129 ± 11 | 0.50 |
| SD-systolic BP (mm Hg) | 10.3 ± 3.0 | 10.2 ± 3.0 | 0.78 |
| Diastolic BP (mm Hg) | 72 ± 7 | 74 ± 6 | 0.15 |
| Urinary ACR (mg/g) | 47 ± 128 | 203 ± 608 | 0.01 |
| Log ACR | 1.3 ± 0.5 | 1.4 ± 0.7 | 0.10 |
| Leucocyte count (103/μL) | 5.7 ± 1.4 | 6.2 ± 1.6 | 0.06 |
| Maximum IMT (mm) | 1.03 ± 0.27 | 1.10 ± 0.39 | 0.17 |
| Mean IMT (mm) | 0.83 ± 0.18 | 0.85 ± 0.19 | 0.49 |
| ACR ≥ 30 mg/g (n, %) | 37 (30) | 16 (40) | 0.26 |
Mean ± SD or n, %. SD-LDLC: standard deviation of low-density lipoprotein cholesterol; OHA: oral hypoglycemic agents; CCB: calcium channel blockers; RASi: renin-angiotensin system inhibitors; PG: plasma glucose; CV: coefficient of variation; eGFR: estimated glomerular filtration rate; BP: blood pressure; ACR: albumin/creatinine ratio; IMT: intima-media thickness.